Gad-M Regimen for Newly Diagnosed Extranodal Nk/T Cell Lymphoma: Analysis of Efficacy and Safety From Phase Ii Study (Nct 01991158)

Hematological Oncology - United Kingdom
doi 10.1002/hon.2437_67